SGS has announced its webinar, ‘USP665 in Practice: Addressing Industry Questions on Single-Use System Compliance’, taking place on 20th November 2025.
Agarose Bead Technologies (ABT), a manufacturer of high-quality agarose resins has today announced plans for further expansion, reinforcing its position as a strategic partner for biopharmaceutical companies developing next-generation therapies.
Elliott Zell, global new product marketing manager for Solventum Bioprocessing Filtration looks at reimagining clarification in biopharmaceutical manufacturing.
RION has announced a collaboration with Lonza to provide cGMP manufacturing and technical support for commercial scale production of its Purified Exosome Product (PEP) drug substance for late phase clinical supply and beyond.
SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, has announced the launch of NK.SET.
Alchemab Therapeutics (Alchemab), a biopharmaceutical company which identifies and develops naturally occurring therapeutic antibodies from resilient individuals, has announced initiation of a Phase 1 first-in-human study of ATLX-1282.
Polpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.
Michael Franco, director of Global Biopharma Sales, PSG Biotech explores the question: "how do we maintain the benefits of single-use while reducing the environmental burden they create?"
